Skip to content

Investors who suffered financial losses due to Nutex Health Inc. (NUTX) are being encouraged to join a class action lawsuit. For more information, reach out to The Gross Law Firm.

Notification from The Gross Law Firm to Nutex Health Inc. (NASDAQ: NUTX) shareholders, dated Sept. 18, 2025.

Investors experiencing financial losses from Nutex Health Inc. (NUTX) are encouraged to join a...
Investors experiencing financial losses from Nutex Health Inc. (NUTX) are encouraged to join a class action lawsuit. For further information, reach out to The Gross Law Firm.

Investors who suffered financial losses due to Nutex Health Inc. (NUTX) are being encouraged to join a class action lawsuit. For more information, reach out to The Gross Law Firm.

In a recent development, shareholders of Nutex Health Inc. (NASDAQ: NUTX) have received a notice from The Gross Law Firm, a nationally recognized class action law firm. The notice concerns potential legal action related to the company's financial reporting practices.

According to the complaint, Nutex Health Inc. is alleged to have overstated the extent to which it had remediated material weaknesses in its internal controls over financial reporting. The complaint further suggests that the company's revenues, particularly those attributable to its engagement with HaloMD in the IDR process, were unsustainable due to fraudulent conduct.

The allegations against HaloMD, a third-party IDR vendor, involve a coordinated scheme to defraud insurance companies during the class period, which spans from August 8, 2024, to August 14, 2025. The complaint also alleges that Nutex Health Inc. was unable to effectively account for the treatment of certain of its stock-based compensation obligations and improperly calculated these obligations as equity rather than liabilities.

These issues, if true, could potentially overstate the company's business and financial prospects, and increase the risk that Nutex Health Inc. would be unable to timely file certain financial reports with the SEC.

The lead plaintiff in the lawsuit against Nutex Health Inc. is not specified in publicly available information. However, shareholders are encouraged to contact The Gross Law Firm regarding possible lead plaintiff appointment. The deadline to seek to be a lead plaintiff in the class action is October 21, 2025.

Shareholders who purchased shares of NUTX during the class period listed are eligible to register for this class action at this link. It is important to note that appointment as lead plaintiff is not required to partake in any recovery.

At this time, the notice does not provide information on the current status of any legal action or the potential compensation for shareholders. For more information, shareholders are advised to visit The Gross Law Firm's website or contact them directly using the contact information provided in the link.

Read also:

Latest